Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma

Clinical Nuclear Medicine

Volumn 21, Issue 3, 1996, Pages 221-226

  Maini, Carlo L ^a,b   Scelsa, Maria G ^a   Fiumara, Concetta ^a   Tofani, Anna ^a   Sciuto, Rosa ^a   Tipaldi, Luigi ^a   D'Annibale, Marco ^a   Santoro, Eugenio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL; IODINATED POPPYSEED OIL I 131; IODINE 131; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; REGIONAL PERFUSION; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; GELATIN SPONGE, ABSORBABLE; HUMANS; INJECTIONS, INTRA-ARTERIAL; IODINE RADIOISOTOPES; IODIZED OIL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TIME FACTORS;

EID: 0030008172     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199603000-00008     Document Type: Article

References (47)

1. 90 radiating microspheres. Ann Surg 162:267, 1965.
2. Grady ED: Intrahepatic arterial 90-yttrium resin spheres to treat liver cancer. J Nucl Med 5:253, 1978.
3. Mantravadi RVP, Spigos DG, Tan WS, et al: Intraarterial yttrium-90 in the treatment of hepatic malignancy. Radiology 142:783, 1982.
4. Grady ED: Adjuvant therapy of Dukes'C colon cancer by intraarterial P-32 colloid for internal radiation therapy of the liver. Am Surg 50:488, 1984.
5. Leichner PK, Klein JL, Siegelman SS, et al: Dosimetry of 131-I-labeled antiferritin in hepatoma: Specific activities in the tumor and liver. Cancer Treat Rep 67:647, 1983.
6. Order SE, Stillwagon GD, Klein JL, et al: Iodine-131-antiferritin: A new treatment modality in hepatoma. A radiation therapy oncology group study. J Clin Oncol 3:1573, 1985.
7. Nakakura K, Tashiro S, Uemura K, et al: Study on anti-cancer treatment with an oily anticancer drug injected into the ligated hepatic artery for liver cancer: Preliminary report (in Japanese). Nichidoku Ihou 24:675, 1979.
8. Takayashu K, Shina Y, Muramatsu Y, et al: Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 162:345, 1987.
9. Konno T, Maeda M, Iwai K, et al: Selective targeting of anticancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer 54:2367, 1984.
10. Nakamura H, Hashimoto T, Oi H, et al: Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783, 1989.
11. Kasugai H, Kojima J, Tatsuta M, et al: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intra-arterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 97:965, 1989.
12. Shibata J, Fujiyama S, Sato T, et al: Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64:1586, 1989.
13. Vetter D, Wenger JJ, Bergier JM, et al: Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a Western comparative study in 60 patients. Hepatology 13:427, 1991.
14. Ohishi H, Yoshimura H, Uchida H, et al: Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 23(Suppl):33, 1989.
15. Yamashita Y, Takahashi M, Koga Y, et al: Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67:385, 1991.
16. Yang CF, Ho YZ, Chang JM, et al: Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 23(Suppl):26, 1989.
17. Kobayashi H, Inoue H, Shimada J, et al: Intra-arterial injection of Adriamycin/mitomycin C Lipiodol suspension in liver metastases. Acta Radiol 28:275, 1987.
18. Kobayashi H, Nakajo M, Shimabukuro K, et al: Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol. Nippon Igaku Hoshasen Gakkai Zasshi 44:96, 1984.
19. Kobayashi H, Hidaka H, Kajiya Y, et al: Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol [Diagn] (Stockh) 27:139, 1986.
20. Madsen MT, Park CH, Thakur ML: Dosimetry of iodine-131 ethiodol in the treatment of hepatoma. J Nucl Med 29:1038, 1988.
21. Nakajo M, Kobayashi H, Shimabukuro K, et al: Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J Nucl Med 29:1066, 1988.
22. Bretagne JF, Raoul JL, Bourguet P, et al: Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 168:547, 1988.
23. Raoul JL, Bourguet P, Bretagne JF, et al: Hepatic artery injection of I-131-labeled Lipiodol. Part I. Biodistribution studies results in patients with hepatocellular carcinoma and liver metastases. Radiology 168:541, 1988.
24. Raoul JL, Bretagne JF, Caucanas JP, et al: Internal radiation therapy for hepatocellular carcinoma: Results of a French multicenter phase II trial of transarterial injection of iodine-131-labeled Lipiodol. Cancer 69:346, 1992.
25. Park CH, Suh JH, Yoo HS, et al: Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: A preliminary report. Nucl Med Commun 8:1075, 1987.
26. Park C, Choi SI, Kim H, et al: Distribution of Lipiodol in hepatocellular carcinoma. Liver 10:72, 1990.
27. Yoo HS, Park CH, Suh JH, et al: Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: Preliminary findings. Cancer Chemother Pharmacol 23(Suppl): 54, 1989.
28. Leung WT, Lau WY, Ho S, et al: Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 35:1313, 1994.
29. Yumoto Y, Jinno K, Inatsuki S, et al: Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution. Cancer Chemother Pharmacol 31(Suppl):128, 1992.
30. Yoo HS, Lee JT, Kim KW, et al: Nodular hepatocellular carcinoma: Treatment with subsegmental intraarterial injection of iodine-131-labeled iodized oil. Cancer 68:1878, 1991.
31. Kajiya Y, Kobayashi H, Nakajo M, et al: Transarterial internal radiation therapy with I-131-Lipiodol for multifocal hepatocellular carcinoma: Immediate and long term results. Cardiovasc Intervent Radiol 16:150, 1993.
32. Pugh RN, Murray-Lyon IM, Dawson JL, et al: Transection of oesophagus for bleeding oesophageal varices. Br J Surg 60: 646, 1973.
33. Quimby EH, Feitelberg S, Gross W: Radioactive nuclides in medicine and biology. Philadelphia, Lea and Febiger, 1970, pp 102-140.
34. Maki S, Konno T, Maeda H: Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 56:751, 1985.
35. Nagasue N, Yukaya H, Hamada T, et al: The natural history of hepatocellular carcinoma: A study of 100 untreated cases. Cancer 54:1461, 1984.
36. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma: Carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 15:918, 1985.
37. Liver Cancer Study Group of Japan: Survey and follow-up study of primary liver cancer in Japan. Report 6. Acta Hepatol Jpn 26:254, 1985.
38. Ihde DC, Matthews MJ, Makuch RW, et al: Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy: Identification of two groups of patients with prospects for prolonged survival. Am J Med 78:399, 1985.
39. Sheen MC, Huang TJ, Sheen PC, et al: Continuous intraarterial infusion chemotherapy of hepatoma. Taiwan I Hsueh Hui Tsa Chih 82:389, 1983.
40. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397, 1983.
41. Hsu HC, Wei TC, Tsang YM, et al: Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 57:1184, 1986.
42. Ryu M, Yamamoto Y, Yamamoto H, et al: Evaluation of the effect of transcatheter arterial embolization (TAE) as a preoperative therapy for minute hepatocellular carcinomas (in Japanese). Acta Hepatol Jpn 25:881, 1984.
43. Ohishi H, Uchida H, Yoshimura H, et al: Hepatocellular carcinoma detected by iodized oil: Use of anticancer agents. Radiology 154:25, 1985.
44. Senger DR, Galli SJ, Dvorak AM, et al: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983, 1983.
45. Yumoto Y, Jinno K, Tokuyama K, et al: Hepatocellular carcinoma detected by iodized oil. Radiology 154:19, 1985.
46. Yang CF, Ho YJ: Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):86, 1992.
47. Hsieh MY, Chang WY, Wang LY, et al: Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol 31(Suppl):82, 1992.